CA-19-0011
SPA will update the effective date for clinical laboratory service rates with a new fee schedule beginning
DE-19-0008
This SPA updates Optional Eligibility Groups which includes Individuals Eligible for Cash Except for Institutionalization, Individuals in Institutions Eligible under a Special Income Level and Ticket to Work Basic.
NE-19-0005
Adds an additional disregard from resources to exempt land or assets held as a life estate when the life tenant cannot sell the asset without agreement from the remainder interest holders for the following eligibility groups subject to 1902(r)(2) of the Act: Medicare Savings
ID-19-0023
Add 1915(I) State Plan Option for reimbursement of state plan substance use disorder services delivered in an IMD setting.
MN-20-0002
CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. In this amendment Minnesota elects to (1) waive cost sharing for COVID-19 testing and treatment, (2) suspend disenrollment due to failure to pay premiums for working disabled BBA group, (3) expand telehealth, and (4) to allow for 90-day refills without prior authorization for certain maintenance drugs.
AL-20-0004
CMS is approving this time-limited state plan amendment to respond to the COVID-19 national emergency. In this amendment Alabama elects to suspend Medicaid copayments for all services for all Medicaid beneficiaries during the time of the Public Health emergency and to utilize telehealth for some Medicaid services.
KS-19-0009
Allows the state to comply with the Medicaid Drug Utilization Review (DUR)
provisions included in Section 1004 of the Substance Use-Disorder Prevention that promotes
Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).
provisions included in Section 1004 of the Substance Use-Disorder Prevention that promotes
Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).
AK-19-0010
Allows the state to comply with the Medicaid Drug Utilization Review (DUR)
provisions included in Section 1004 of the Substance Use-Disorder Prevention that promotes
Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).
provisions included in Section 1004 of the Substance Use-Disorder Prevention that promotes
Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (P.L. 115-271).
Section 1135 Waiver Flexibilities - Michigan Coronavirus Disease 2019
On March 13, 2020, pursuant to section 1135(b) of the Act, the Secretary of the United States Department of Health and Human Services invoked his authority to waive or modify certain requirements of titles XVIII, XIX, and XXI of the Act as a result of the consequences of the COVID-19 pandemic, to the extent necessary, as determined by the Centers for Medicare & Medicaid Services (CMS)
Collections:
CMS Guidance: Reporting Individuals Who Receive Medicaid Coverage for COVID-19 Testing in the T-MSIS Eligible File
This guidance specifies state reporting requirements for Transformed Medicaid Statistical Information (T-MSIS) enrollment data for uninsured individuals who receive limited Medicaid coverage for COVID-19 testing. Coronavirus Disease 2019, or COVID-19, is a respiratory disease caused by a novel coronavirus.[1] The U.S. Secretary of Health and Human Services Alex M. Azar II declared a public health emergency as a result of confirmed cases of COVID-19 in the United States. The declaration is retroactive to January 27, 2020.[2] This document provides guidance to states for reporting these individuals in the T-MSIS Eligible file.
Collections: